Latest News from: Houston Methodist

Filters close
Released: 1-Nov-2024 4:00 PM EDT
Houston Methodist Researchers Shed Light on Increased Rates of Severe Human Infections Caused by Streptococcus Subspecies
Houston Methodist

A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called Streptococcus dysgalactiae subspecies equisimilis (SDSE). SDSE infects humans via the skin, throat, gastrointestinal tract and female genital tract to cause infections ranging in severity from strep throat (pharyngitis) to necrotizing fasciitis (flesh-eating disease).

Released: 3-Oct-2024 7:05 PM EDT
Houston Methodist Part of National Consortium to Develop Vaccine Against Herpesviruses
Houston Methodist

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government’s Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

Released: 3-Oct-2024 7:05 PM EDT
New Addition to Standard-of-Care Treatments for Non-Small-Cell Lung Cancer Patients Has Potential to Increase Progression-Free Survival
Houston Methodist

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common type of lung cancer.

Released: 3-Oct-2024 7:05 PM EDT
Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium
Houston Methodist

The question isn’t if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.

Newswise: gutmicrobiomeslide-web-size.ashx?mw=1382&hash=7D2FD08137CF7FCFD8BD3433DC214D3D
Released: 18-Sep-2024 4:05 PM EDT
Houston Methodist and Rice University team up to track gut-brain connection
Houston Methodist

For the next two years, 120 Division I Rice University athletes will be part of a concussion study with Houston Methodist researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging cannot.

Newswise:  Neurology ‘house calls’ to improve quality of care and life for ALS patients
Released: 18-Jun-2024 2:05 PM EDT
Neurology ‘house calls’ to improve quality of care and life for ALS patients
Houston Methodist

When second-year neurology resident Dr. Keelie Denson asked her ALS (Amyotrophic Lateral Sclerosis) patients what they found most lacking in ALS care, the answer was easy for Angela Amar. She and her three children, now adults, had been caring for her husband Robert for more than 14 years.

Released: 12-Jun-2024 1:05 PM EDT
Researchers at Houston Methodist find survival improves with open radical hysterectomy in early stage cancer
Houston Methodist

Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches, according to a 5-year study led by Houston Methodist researchers and published in the Journal of Clinical Oncology.

Newswise: Researchers at Houston Methodist find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness
Released: 30-Apr-2024 5:05 PM EDT
Researchers at Houston Methodist find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness
Houston Methodist

A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This could impact the way cancer of the pancreas is treated.

Newswise: Using AI to Speed Up Vaccine Development Against Disease X
Released: 18-Jul-2023 9:00 AM EDT
Using AI to Speed Up Vaccine Development Against Disease X
Houston Methodist

CEPI to provide up to $4.98 USD million to Houston Methodist Research Institute-led consortium to use artificial intelligence for design of vaccines to fight diseases with pandemic potential. The project will support a consortium, led by HMRI, to design potential antigenic targets for up to 10 priority virus families with epidemic or pandemic potential. Laboratory-based tests will then be used to verify antigen designs for possible further development.

Newswise: New analysis shows COVID variant and severity of illness influence cardiac dysfunction, a key indicator of long COVID
Released: 5-Jun-2023 12:05 PM EDT
New analysis shows COVID variant and severity of illness influence cardiac dysfunction, a key indicator of long COVID
Houston Methodist

Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID, according to a recent study published in the European Heart Journal – Cardiovascular Imaging. Patients recovering from the omicron variant were least likely to have microvascular involvement. The study also found that microvascular dysfunction started to be seen less often after nine months to one year following infection suggesting that this type of abnormality may be reversible.

Released: 5-May-2023 2:35 PM EDT
Houston Methodist Hospital reaches 10,000 transplant milestone
Houston Methodist

Surgeons at Houston Methodist Hospital successfully completed its 10,000th organ transplant yesterday.

Newswise: Study suggests longer time between COVID-19 vaccines more effective for some
Released: 18-Apr-2023 7:20 PM EDT
Study suggests longer time between COVID-19 vaccines more effective for some
Houston Methodist

A recent Houston Methodist study may offer some guidance on when certain populations should get their next booster. A research team of computational medicine and data scientists from the Houston Methodist Research Institute predicted the immune response to COVID-19 vaccines with a math model they developed, and also found that current CDC dosing intervals may require customization to protect all individuals alike.

Newswise: Implantable device shrinks pancreatic tumors
Released: 13-Apr-2023 2:35 PM EDT
Implantable device shrinks pancreatic tumors
Houston Methodist

Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of rice.

   
Newswise: Researchers discover way to reverse infertility by reducing HDL cholesterol
Released: 16-Mar-2023 5:05 PM EDT
Researchers discover way to reverse infertility by reducing HDL cholesterol
Houston Methodist

Houston Methodist scientists reversed infertility in sterile mice by reducing HDL cholesterol with a bacterial protein in a promising development that shows further evidence linking high cholesterol to female infertility. The researchers worked with a protein called serum opacity factor that lowered cholesterol levels by over 40% in three hours.



close
0.14589